Lymph node study for kidney cancer patients
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at lymph nodes in people with known or suspected kidney cancer to learn more about the disease. It may help researchers understand how kidney cancer affects the lymph system.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have known or suspected kidney cancer.
- You are not pregnant or breastfeeding.
- You do not have an allergy to iodine.
- You are being seen at Yale New Haven Hospital or Smilow Cancer Hospital.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at kidney cancer that has spread to nearby lymph nodes but not to distant parts of the body. Researchers will test the tumor tissue to understand how it works and which drugs might kill the cancer cells, which could help guide future treatment choices.
This study is for people with high-risk kidney cancer who are having their whole kidney removed. It compares surgery alone versus surgery plus removing lymph nodes from the tumor area to see if removing the nodes helps control the cancer better.
This study aims to deeply analyze immune cells and tumor cells in the blood and tumors of cancer patients. It may help researchers better understand how the immune system interacts with cancer.
This study looks for “biomarkers,” which are measurable signs (often from blood or tissue), to better understand kidney cancer. It may help doctors identify who has kidney cancer and how it behaves.
This study looks at whether a simple blood test can detect tiny bits of kidney cancer DNA after surgery. If successful, it could help doctors spot a return of cancer earlier than scans alone.
This study collects blood and tissue samples from people with cancer or suspected cancer, or from their blood relatives. Researchers use these samples to better understand cancer and develop new treatments.
Hear when a new Renal Cell Carcinoma (RCC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.